Fundz

Neutrolis Inc. reported raising $23.1 Million in an initial SEC Form D filing, from an offering of $40.6 Million

PRIVATEDec 03, 2021$23.1M of $40.6M raised

Amount Raised

$23.1 Million

$23.1 Million sold, per SEC Form D (first sale Dec 3, 2021)

Round Type

Venture

CambridgeBiotechnology

Quick answer

Neutrolis raised $23.1 Million in a funding round, dated December 3, 2021. Neutrolis is based in Cambridge, Massachusetts, United States.

How much did Neutrolis raise?
Neutrolis raised $23.1 Million in a funding round on December 3, 2021.
What does Neutrolis do?
Neutrolis, Inc. is a biotechnology company developing therapeutics that target neutrophils, the most abundant immune cell in our body.
Where is Neutrolis based and how big is it?
Neutrolis is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at Neutrolis?
Fundz holds 1 contact at Neutrolis, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Neutrolis that raised within 45 days of this round, from Fundz verified event records.

  • Revi R Therapeutics raised $20M (Funding Round) on January 17, 2022.
  • Alterome Therapeutics, Inc. raised $64M on January 14, 2022.
  • DermBiont raised $33M (Seed) on January 14, 2022.
  • PostEra Inc. raised $26M on January 14, 2022.
  • Arda Therapeutics raised $7.5M on January 14, 2022.
  • Co-Diagnostics, Inc. raised $47M on January 14, 2022.

Who to call at Neutrolis, and when

A new round usually means Neutrolis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neutrolis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neutrolis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neutrolis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neutrolis

Location

1 BROADWAY, FLOOR 14

Cambridge, Massachusetts, United States

About

Neutrolis, Inc. is a biotechnology company developing therapeutics that target neutrophils, the most abundant immune cell in our body. Neutrolis’ lead program targets Neutrophil Extracellular Traps (NETs). NETs are a fundamental arm of the innate immune system and play an important role in chronic and acute diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neutrolis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRalph L., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Neutrolis's next move

See what Strategic adds

Neutrolis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.